AVE — Avecho Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00- AU$34.90m
- AU$30.25m
- AU$1.24m
Annual cashflow statement for Avecho Biotechnology, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.516 | 1.04 | 0.759 | 1.13 | 1.7 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.1 | -1.67 | -3.18 | -3.97 | 1.1 |
| Capital Expenditures | -0.203 | -0.053 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.016 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.203 | -0.053 | 0 | -0.016 | 0 |
| Financing Cash Flow Items | -0.294 | 0 | -0.717 | 0 | -0.187 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.69 | -0.078 | 7.22 | 0.855 | 1.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.39 | -1.8 | 4.04 | -3.13 | 2.29 |